TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) - ANVISA Registration 10033120654

Access comprehensive regulatory information for TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10033120654 and manufactured by BECKMAN COULTER, INC.. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Aug 01, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.